Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lynk Pharmaceuticals Co., Ltd

Clinical trials sponsored by Lynk Pharmaceuticals Co., Ltd, explained in plain language.

Trials to join now! 1 Not yet finished but already full! 1 Completed 2

New hope for arthritis patients: experimental drug targets inflammation

Disease control Ongoing

This study tests a new drug called LNK01001 (Zemprocitinib) in 430 adults with moderate-to-severe rheumatoid arthritis who did not get enough relief from other treatments. The drug aims to reduce joint pain and swelling by targeting inflammation. Participants will receive either …

Phase: PHASE3 • Sponsor: Lynk Pharmaceuticals Co., Ltd • Aim: Disease control

Last updated May 08, 2026 12:04 UTC